Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis.
Anees BahjiDylan ErmacoraCallum StephensonEmily R HawkenGustavo VazquezPublished in: Canadian journal of psychiatry. Revue canadienne de psychiatrie (2020)
The evidence for augmentation strategies in bipolar depression is limited to a handful of agents. Fluoxetine appeared to have the most consistent evidence base for both efficacy and tolerability. There remains a need for additional research exploring novel treatment strategies for bipolar depression, particularly head-to-head studies.